Lucira Health Inc reports results for the quarter ended in September - Earnings Summary

Lucira Health

14/11/2022 21:42

* Lucira Health Inc  LHDX.OQ  reported a quarterly adjusted
loss
of $3.15​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 38 cents per share.
    * Revenue rose 129.6% to $34.39 million from a year ago;
analysts
expected $32.79 million. 
    * Lucira Health Inc's reported EPS for the quarter was a
loss of
$3.15​.
    * The mean earnings estimate of analysts had fallen by
about 16.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Lucira Health Inc shares had fallen by 33.9% this
quarter and
lost 91.9% so far this year.
    * The company reported a quarterly loss of $126.86 million.
    * Wall Street's median 12-month price target for Lucira
Health Inc
is $3.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 09:42 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.38          -3.15          Missed
 Jun. 30 2022      -0.34          -0.45          Missed
 Mar. 31 2022      -0.08          0.40           Beat
 Dec. 31 2021      -0.55          0.01           Beat